ORIC Pharmaceuticals is a Biotech company based in South San Francisco. It has raised $900M in total funding. Latest round: IPO.
ORIC Pharmaceuticals funding overview
ORIC Pharmaceuticals is a Biotech company based in South San Francisco. ORIC Pharmaceuticals has raised $900M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in April 2020. The round record for ORIC Pharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include The Column Group, Topspin Partners, OrbiMed Advisors, EcoR1 Capital, Fidelity Management & Research Company. 5 distinct backers are named across the disclosed rounds.
ORIC Pharmaceuticals at a glance
Total raised
$900M
Latest round
IPO
Latest round date
April 2020
Industry
Biotech
Headquarters
South San Francisco
Notable investors
The Column Group, Topspin Partners, OrbiMed Advisors, EcoR1 Capital, Fidelity Management & Research Company
Frequently asked about ORIC Pharmaceuticals funding
How much has ORIC Pharmaceuticals raised?
ORIC Pharmaceuticals has raised $900M in total disclosed funding across the rounds on record.
Who has invested in ORIC Pharmaceuticals?
The Column Group, Topspin Partners, OrbiMed Advisors, EcoR1 Capital, Fidelity Management & Research Company are named among the investors backing ORIC Pharmaceuticals.
What was the latest ORIC Pharmaceuticals funding round?
The most recent disclosed round is an IPO, announced in April 2020.
Where is ORIC Pharmaceuticals based?
ORIC Pharmaceuticals is based in South San Francisco.
What sector does ORIC Pharmaceuticals operate in?
ORIC Pharmaceuticals is tracked under Biotech from South San Francisco, with $900M in disclosed funding.
When did ORIC Pharmaceuticals last raise?
The last disclosed ORIC Pharmaceuticals round closed in April 2020 at IPO.
Round data for ORIC Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in South San Francisco and backer lists below.
